San Mateo, CA, United States of America

Avi J Ashkenazi

USPTO Granted Patents = 78 

 

 

Average Co-Inventor Count = 3.1

ph-index = 20

Forward Citations = 966(Granted Patents)

Forward Citations (Not Self Cited) = 890(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1994-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-FGFR3 Antibodies
Cancer Drug Resistance
Apoptosis Induction
Biomarker Assays
Apo-2 Receptor Polypeptides
Non-Hodgkin's Lymphoma
SCD1 Antagonists
Inflammatory Bowel Disease
TAT294 Polypeptides
Divalent Metal Ions
Tumor Diagnosis
Complement-Associated Disorders
78 patents (USPTO):Explore Patents

Title: Avi J Ashkenazi - Innovator in Biomedical Technologies

Introduction:

Avi J Ashkenazi is a distinguished innovator based in San Mateo, CA, with a remarkable track record in the field of biomedical technologies. With a total of 78 patents to his name, Ashkenazi's latest inventions have revolutionized the landscape of antibody therapies and drug treatments for a range of diseases and disorders.

Latest Patents:

Among Ashkenazi's recent patents is the groundbreaking invention of Anti-FGFR3 antibodies, which offer new avenues for combating specific types of cancers and other medical conditions associated with abnormal cell growth. Additionally, his discovery of Pyrimidinyl-pyridyloxy-naphthyl compounds presents novel approaches to treating IRE1-related diseases and disorders, marking significant progress in personalized medicine.

Career Highlights:

Throughout his career, Ashkenazi has made pivotal contributions to renowned companies in the biomedical sector, including Genentech, Inc. (referred to as Genentech, Inc.). His expertise and innovative spirit have been instrumental in shaping the future of pharmaceutical research and development, earning him a reputation as a visionary in the industry.

Collaborations:

Ashkenazi has collaborated closely with notable peers such as Audrey Goddard and Austin L Gurney, fostering a culture of innovation and knowledge sharing within his professional network. These collaborations have led to synergistic breakthroughs in drug discovery and biotechnological advancements, showcasing Ashkenazi's ability to thrive in dynamic team environments.

Conclusion:

In conclusion, Avi J Ashkenazi stands as a pioneering force in the realm of biomedical technologies, with a rich tapestry of patents and inventions that continue to drive progress in healthcare and pharmaceutical sciences. His unwavering commitment to innovation and his collaborative spirit exemplify the essence of a true inventor, leaving an indelible mark on the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…